Depression in the dictionary

(Image by Feng Yu on Shutterstock)

STANFORD, Calif. — Depression and anxiety disorders are among the most common mental health issues worldwide, yet current treatments often fail to provide relief for many sufferers. A major challenge has been the heterogeneity of these conditions. Patients with the same diagnosis can have vastly different symptoms and underlying brain dysfunctions. Now, a team of researchers at Stanford University has developed a novel approach to parse this heterogeneity, identifying six distinct “biotypes” of depression and anxiety based on specific patterns of brain circuit dysfunction.

The study, published in Nature Medicine, analyzed brain scans from over 800 patients with depression and anxiety disorders. By applying advanced computational techniques to these scans, the researchers were able to quantify the function of key brain circuits involved in cognitive and emotional processing at the individual level. This allowed them to group patients into biotypes defined by shared patterns of circuit dysfunction, rather than relying solely on symptoms.

Intriguingly, the six biotypes showed marked differences not just in their brain function, but also in their clinical profiles. Patients in each biotype exhibited distinct constellations of symptoms, cognitive impairments, and critically, responses to different treatments. For example, one biotype characterized by hyperconnectivity in circuits involved in self-referential thought and salience processing responded particularly well to behavioral therapy. Another, with heightened activity in circuits processing sadness and reward, was distinguished by prominent anhedonia (inability to feel pleasure).

These findings represent a significant step towards a more personalized, brain-based approach to diagnosing and treating depression and anxiety. By moving beyond one-size-fits-all categories to identify subgroups with shared neural mechanisms, this work opens the door to matching patients with the therapies most likely to help them based on the specific way their brain is wired. It suggests that brain circuit dysfunction may be a more meaningful way to stratify patients than symptoms alone. In the future, brain scans could be used to match individual patients with the treatments most likely to work for them, based on their specific neural profile.

More broadly, this study highlights the power of a transdiagnostic, dimensional approach to understanding mental illness. By focusing on neural circuits that cut across traditional diagnostic boundaries, we may be able to develop a more precise, mechanistic framework for classifying these conditions.

“To our knowledge, this is the first time we’ve been able to demonstrate that depression can be explained by different disruptions to the functioning of the brain,” says the study’s senior author, Dr. Leanne Williams, a professor of psychiatry and behavioral sciences, and the director of Stanford Medicine’s Center for Precision Mental Health and Wellness. “In essence, it’s a demonstration of a personalized medicine approach for mental health based on objective measures of brain function.”

The 6 Biotypes Of Depression

  1. The Overwhelmed Ruminator: This biotype has overactive brain circuits involved in self-reflection, detecting important information, and controlling attention. People in this group tend to have slowed-down emotional reactions and attention, but respond well to talk therapy.
  2. The Distracted Impulsive: This biotype has underactive brain circuits that control attention. They tend to have trouble concentrating and controlling impulses, and don’t respond as well to talk therapy.
  3. The Sensitive Worrier: This biotype has overactive brain circuits that process sadness and reward. They tend to have trouble experiencing pleasure and positive emotions.
  4. The Overcontrolled Perfectionist: This biotype has overactive brain circuits involved in regulating behavior and thoughts. They tend to have excessive negative emotions and threat sensitivity, trouble with working memory, but respond well to certain antidepressant medications.
  5. The Disconnected Avoider: This biotype has reduced connectivity in emotion circuits when viewing threatening faces, and reduced activity in behavior control circuits. They tend to have less rumination and faster reaction times to sad faces.
  6. The Balanced Coper: This biotype doesn’t show any major overactivity or underactivity in the brain circuits studied compared to healthy people. Their symptoms are likely due to other factors not captured by this analysis.

Of course, much work remains to translate these findings into clinical practice. The biotypes need to be replicated in independent samples and their stability over time needs to be established. We need to develop more efficient and scalable ways to assess circuit function that could be deployed in routine care. And ultimately, we will need prospective clinical trials that assign patients to treatments based on their biotype.

Nevertheless, this study represents a crucial proof of concept. It brings us one step closer to a future where psychiatric diagnosis is based not just on symptoms, but on an integrated understanding of brain, behavior, and response to interventions. As we continue to map the neural roots of mental illness, studies like this light the way towards more personalized and effective care for the millions of individuals struggling with these conditions.

“To really move the field toward precision psychiatry, we need to identify treatments most likely to be effective for patients and get them on that treatment as soon as possible,” says Dr. Jun Ma, the Beth and George Vitoux Professor of Medicine at the University of Illinois Chicago. “Having information on their brain function, in particular the validated signatures we evaluated in this study, would help inform more precise treatment and prescriptions for individuals.”

Paper Summary


To map the neural landscape of depression, the researchers collected functional MRI scans from 801 patients with a range of depression and anxiety diagnoses. The scans were acquired both while patients rested and while they performed specific cognitive and emotional tasks designed to probe the function of different brain circuits.

Using an innovative image processing system, the team quantified 41 different measures of circuit function for each individual, spanning key networks involved in self-referential thought (default mode), salience processing, attention, cognitive control, and emotion processing. Critically, they expressed these measures as deviations from a reference group of healthy individuals, creating standardized scores of circuit dysfunction.

These personalized scores were then fed into a clustering algorithm, which grouped patients based on the similarity of their brain dysfunction profiles. The researchers rigorously validated the resulting biotypes using a battery of statistical tests and by evaluating their alignment with a pre-established theoretical framework of neural dysfunction in depression and anxiety.


The analysis revealed six robust biotypes, each characterized by a unique profile of hyper- or hypo-activation and connectivity in specific brain circuits. While some biotypes were distinguished mainly by altered function in circuits active during rest, others showed dysfunctions that emerged during active cognitive and emotional processing.

Importantly, these brain-based biotypes cut across traditional diagnostic boundaries, with each one including patients with a mix of depression, anxiety, and related diagnoses. This supports the notion that the neural substrates of these disorders do not neatly map onto symptom-based categories.

Even more striking were the clinical differences between biotypes. Patients in each biotype showed distinct profiles of symptom severity, everyday cognitive deficits, and crucially, therapeutic response. Certain biotypes responded preferentially to specific antidepressants, while others showed the greatest improvement with behavioral interventions.


While groundbreaking, the study has some limitations. The biotypes were derived from a specific set of brain scan paradigms and analytic choices; it remains to be seen whether the same categories would emerge with different tasks or computational approaches. The sample, though large and diverse, may not capture the full spectrum of depression and anxiety presentations. Finally, treatment outcomes were only available for a subset of patients and varied in their measurement across studies.

About StudyFinds Staff

StudyFinds sets out to find new research that speaks to mass audiences — without all the scientific jargon. The stories we publish are digestible, summarized versions of research that are intended to inform the reader as well as stir civil, educated debate. StudyFinds Staff articles are AI assisted, but always thoroughly reviewed and edited by a Study Finds staff member. Read our AI Policy for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink


Chris Melore


Sophia Naughton

Associate Editor